A recent UK study shows that COVID-19-positive patients who were given ivermectin recovered faster than those who weren’t.
The large-scale open-label trial involved 2,157 participants who received ivermectin and 3,256 who received typical care from June 23, 2021, to July 1, 2022. According to the research published in the Journal of Infection, ivermectin recipients recovered two days faster with a significant statistical difference. The report further indicates that compared to the four percent of patients receiving standard care, only 1.6 percent of those given ivermectin had to be hospitalized or died.
The use of ivermectin to treat COVID-19, which was encouraged by former President Donald Trump, proved controversial.
The US Food and Drug Administration (FDA) encouraged Americans not to use it for treatment, stating: “You are not a horse. You are not a cow. Seriously y’all. Stop it.” A US appeals court found the FDA’s move overstepped its authority.